Hypocretins and primary headaches: neurobiology and clinical implications

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Expert Review of Neurotherapeutics

• Publication date

  2008-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1586/14737175.8.3.409PMID 18345971
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The International Classification of Headache Disorders

  2008cited by this paper
• Involvement of Corticotrophin-Releasing Factor and Orexin-A in Chronic Migraine and Medication-Overuse Headache: Findings From Cerebrospinal Fluid

  2008cited by this paper
• Association Between Migraine and the G1246A Polymorphism in the Hypocretin Receptor 2 Gene

  2007cited by this paper
• Implication of protein kinase C in the orexin‐induced elevation of extracellular dopamine levels and its rewarding effect

  2007cited by this paper
• Association between the G1246A polymorphism of the hypocretin receptor 2 gene and cluster headache: a meta-analysis

  2007cited by this paper
• Hypothalamic Activation in Spontaneous Migraine Attacks

  2007cited by this paper
• Obesity, migraine, and chronic migraine

  2007cited by this paper
• Hypocretin (orexin) loss in Parkinson's disease.

  2007cited by this paper
• The 1246 G/A polymorphism of the HCRTR2 gene is not associated with migraine

  2007cited by this paper
• Sympathetic and hyperthermic reactions by orexin A: role of cerebral catecholaminergic neurons.

  2007cited by this paper
• Migraine prevalence, disease burden, and the need for preventive therapy

  2007cited by this paper
• Circannual periodicity of migraine?

  2007cited by this paper
• The G1246A Polymorphism in the Hypocretin Receptor 2 Gene is not Associated with Treatment Response in Cluster Headache

  2007cited by this paper
• Cluster headache is associated with the G1246A polymorphism in the hypocretin receptor 2 gene

  2006cited by this paper
• Hypnic headache: an update

  2006cited by this paper
• A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort

  2006cited by this paper
• Cost of disorders of the brain in Europe.

  2006cited by this paper
• Posterior hypothalamic activation in paroxysmal hemicrania

  2006cited by this paper
• Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat

  2006cited by this paper
• Medication-overuse headache in patients with cluster headache

  2006cited by this paper
• A role for lateral hypothalamic orexin neurons in reward seeking

  2005cited by this paper
• Neurobiology in primary headaches.

  2005cited by this paper
• Cost of disorders of the brain in Europe

  2005cited by this paper
• Orexin inputs to caudal raphé neurons involved in thermal, cardiovascular, and gastrointestinal regulation

  2005cited by this paper
• Persistent pain and stress activate pain-inhibitory orexin pathways

  2005cited by this paper
• Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates.

  2005cited by this paper
• A polymorphism of the hypocretin receptor 2 gene is associated with cluster headache

  2004cited by this paper
• Analgesic effect of intrathecal administration of orexin on neuropathic pain in rats.

  2004cited by this paper
• The International Classification of Headache Disorders (2nd ed.)

  2004cited by this paper
• Migraine as a risk factor for subclinical brain lesions.

  2004cited by this paper
• Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area

  2004cited by this paper
• A Report on the Journal 2004

  2004cited by this paper
• The hypocretin/orexin system in health and disease.

  2003cited by this paper
• Morphological study of orexin neurons in the hypothalamus of the Long-Evans rat, with special reference to co-expression of orexin and NADPH-diaphorase or nitric oxide synthase activities.

  2003cited by this paper
• Quality of life and disability in primary chronic daily headaches

  2003cited by this paper
• The International Classification of Headache Disorders: 2nd edition

  2003cited by this paper
• Parodoxical effect of orexin A: hypophagia induced by hyperthermia

  2003cited by this paper
• Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes.

  2003cited by this paper
• Analgesic effect of intrathecally administered orexin‐A in the rat formalin test and in the rat hot plate test

  2002cited by this paper
• Functions of the orexinergic/hypocretinergic system.

  2002cited by this paper
• The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.

  2002cited by this paper
• Migraine--current understanding and treatment.

  2002cited by this paper
• Cluster Headache: Evidence for a Disorder of Circadian Rhythm and Hypothalamic Function

  2002cited by this paper
• Pathophysiology of cluster headache: a trigeminal autonomic cephalgia.

  2002cited by this paper
• Orexin-A Regulates Body Temperature in Coordination with Arousal Status

  2001cited by this paper
• Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines.

  2001cited by this paper
• The posterior hypothalamic area: chemoarchitecture and afferent connections.

  2001cited by this paper
• CSF hypocretin/orexin levels in narcolepsy and other neurological conditions

  2001cited by this paper
• Reduced Number of Hypocretin Clinical Study Neurons in Human Narcolepsy

  2000cited by this paper
• The novel brain neuropeptide, orexin‐A, modulates the sleep–wake cycle of rats

  2000cited by this paper
• The global burden of disease study: implications for neurology.

  2000cited by this paper
• Hypocretin (orexin) deficiency in human narcolepsy.

  2000cited by this paper
• Structure, tissue distribution, and pharmacological characterization of Xenopus orexins.

  1999cited by this paper
• Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight.

  1999cited by this paper
• Correlation between structural and functional changes in brain in an idiopathic headache syndrome

  1999cited by this paper
• Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord.

  1999cited by this paper
• Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems.

  1999cited by this paper
• The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity.

  1998cited by this paper
• Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.

  1998cited by this paper
• Neurons Containing Hypocretin (Orexin) Project to Multiple Neuronal Systems

  1998cited by this paper
• Hypothalamic activation in cluster headache attacks.

  1998cited by this paper
• Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.

  1998cited by this paper
• Effects of lesion and stimulation of rat hypothalamic arcuate nucleus on the pain system.

  1988cited by this paper
• Obesity, migraine, and chronic migraine Possible mechanisms of interaction

  year unknowncited by this paper

• Bidirectional Mendelian Randomization Analysis of 338 Cerebrospinal-Fluid Metabolites and Cluster-Headache Risk

  2026cites this paper
• The Orexin System and Its Impact on the Autonomic Nervous and Cardiometabolic System in Post-Acute Sequelae of COVID-19

  2025cites this paper
• Treating episodic migraine with precision: the evolving landscape of targeted therapies driven by insights in disease biology

  2025cites this paper
• Gene polymorphism association studies in cluster headache: A field synopsis and systematic meta‐analyses

  2021cites this paper
• Hypothalamic functional MRI activity in the initiation phase of spontaneous and glyceryl trinitrate‐induced migraine attacks

  2021cites this paper
• Analysis of HCRTR2, GNB3, and ADH4 Gene Polymorphisms in a Southeastern European Caucasian Cluster Headache Population

  2019cites this paper
• Caffeine and Primary (Migraine) Headaches—Friend or Foe?

  2019cites this paper
• Orexins and stress.

  2018cites this paper
• Orexin system: Network multi-tasking

  2018cites this paper
• Tackling the perils of unawareness: the cluster headache case

  2017cites this paper
• Orexin System: The Key for a Healthy Life

  2017cites this paper
• Dual orexin receptor antagonist 12 inhibits expression of proteins in neurons and glia implicated in peripheral and central sensitization.

  2014cites this paper
• Is HCRTR2 a Genetic Risk Factor for Alzheimer's Disease?

  2014cites this paper
• Genes and primary headaches: discovering new potential therapeutic targets

  2013cites this paper
• Advances in Drug Development for Acute Migraine

  2012cites this paper
• Normal hypocretin-1 (orexin A) levels in cerebrospinal fluid in patients with idiopathic intracranial hypertension.

  2012cites this paper
• Evidence for an association between migraine and the hypocretin receptor 1 gene

  2011cites this paper
• Orexin-A CSF levels correlate with anxiety but not excessive daytime sleepiness in chronic migraine Orexina-A se correlaciona com ansiedade mas não sonolência diurna no líquido cefalorraquiano de pacientes com enxaqueca crônica

  2011cites this paper
• Current and emerging therapies for migraine prevention and treatment.

  2010cites this paper
• El hipotálamo en el SUNCT:: similitudes y diferencias con las otras cefaleas trigeminoautonómicas

  2009cites this paper